IMFINZI 50 mg/mL concentrate for solution for infusion.
IFCT-1802
Phase 2 small_molecule active
Quick answer
IMFINZI 50 mg/mL concentrate for solution for infusion. for Non small cell lung cancer, Poor general status is a Phase 2 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- Non small cell lung cancer, Poor general status
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active